Mission
The Viral Hemorrhagic Fever Immuotherapeutic Consortium, together discovers lifesaving antibody treatments for pre- or post-exposure protection against deadly viruses.
The Viral Hemorrhagic Fever Immuotherapeutic Consortium, together discovers lifesaving antibody treatments for pre- or post-exposure protection against deadly viruses.
The world’s experts united. Antibodies and research strategies both thoroughly vetted. Rapid identification of therapeutic options. Comprehensive analysis to expand medical arsenal and speed future work.
Antibodies
Biochemistry
In Vivo Studies
Structural Biology
Engineering
In Vitro Evaluation
Immune Effector Functions
Machine Learning